| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/06/2008 | EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1163002B1 Polycationic carbohydrates as immunostimulants in vaccines |
| 08/06/2008 | EP1157042B1 Production of tetravalent antibodies |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | EP0941241B1 Bordetella strain expressing the fha hybrid, |
| 08/06/2008 | CN101238131A Bridged piperazine and piperidine derivatives as CCR1 antagonists |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101235375A Chicken interleukins 16 gene and its eukaryon expression plasmid construction and immunity effect |
| 08/06/2008 | CN101235374A Chicken interleukins 1beta gene and its eukaryon expression plasmid construction and immunity effect |
| 08/06/2008 | CN101235373A RG gene sequence for diffusivity large B cell lymphoma correlation antigen specific TCR Vbeta13 subfamily and application thereof |
| 08/06/2008 | CN101235038A Immunity inhibitor glycyrol |
| 08/06/2008 | CN101234179A Method for preparing lupus erythematosus zhiliao ling |
| 08/06/2008 | CN101234171A Health product with blood fat lowering and preventing and treating cardio-cerebralvascular disease function and preparation thereof |
| 08/06/2008 | CN101234145A Chinese medicinal composition for relieving itching, preparation and application thereof |
| 08/06/2008 | CN101234096A Pidotimod capsule preparation and preparation thereof |
| 08/06/2008 | CN100408583C Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 08/06/2008 | CN100408579C Xanthine derivative, production and use thereof as a medicament |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/06/2008 | CN100408089C Animal medicine capable of resisting multiple irritated stress of chicken |
| 08/06/2008 | CN100408052C Medicine composition for treating chronic heart failure and hypotension and its preparation and use |
| 08/06/2008 | CN100408039C 止痒剂 Antipruritics |
| 08/05/2008 | US7408065 P2X7 receptor antagonists and their use |
| 08/05/2008 | US7408037 Polypeptide that, when mixed with a peripheral blood-mononuclear cell culture and incubated, induces cytotoxic T lymphocytes that contain HLA-A2-restricted cytotoxic T lymphocytes; anti-cancer vaccine |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407931 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407651 IFN-β liquid formulations |
| 08/05/2008 | CA2667965A1 Prophylactic tuberculosis vaccine |
| 08/05/2008 | CA2286482C Nkt cell-activating agents containing .alpha.-glycosylceramides |
| 08/05/2008 | CA2273922C Novel saponin compositions and uses thereof |
| 08/05/2008 | CA2246715C Antibody variants |
| 08/05/2008 | CA2163989C Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 07/31/2008 | WO2008092015A2 Use of hsp20 peptides for treating airway smooth muscle disorders in subjects desensitized to ss -adrenergic receptor agonist therapy |
| 07/31/2008 | WO2008091908A2 Human cancer stem cells |
| 07/31/2008 | WO2008091643A2 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090901A1 Chronic rejection inhibitor |
| 07/31/2008 | WO2008090174A1 New anti-malaria vaccine compositions and uses thereof |
| 07/31/2008 | WO2008089567A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089566A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008069688A3 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008057580A3 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/31/2008 | WO2008051795A3 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 07/31/2008 | WO2008031092A9 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 07/31/2008 | WO2008031061A3 Anti-activin a antibodies and uses thereof |
| 07/31/2008 | WO2007085815A8 Ligands that bind il-4 and/or il-13 |
| 07/31/2008 | US20080182977 Molecules associated with cell proliferation |
| 07/31/2008 | US20080182975 Framework-Patched Immunoglobulins |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182867 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/31/2008 | US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer |
| 07/31/2008 | US20080182845 Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| 07/31/2008 | US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 07/31/2008 | US20080182837 New chemical compounds |
| 07/31/2008 | US20080182831 e.g. Cyanomethyl (6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate; glucocorticoid receptor agonists of the androstane series; with other beta 2-adrenoreceptor agonist; asthma, rhinitis, eczema |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182818 Th1 CELL DIFFERENTIATION ACCELERATOR |
| 07/31/2008 | US20080182803 extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders |
| 07/31/2008 | US20080182786 Target protein is supported on carrier made from a clay mineral, and by adding this to cells it is possible to introduce the target protein into the cells; clay mineral is preferably a layered clay mineral such as montmorillonite, vermiculite, and illite |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181949 Nanoemulsion Vaccines |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181915 Cd40 ligand adjuvant for respiratory syncytial virus |
| 07/31/2008 | US20080181912 Nucleotide sequences encoding vector expressing in vivo at least one immunogen of pathogen and an in vivo expression vector comprising a polynucleotide encoding a polypeptide having an insulin-like growth factor IGF-1 activity; immunogenic composition |
| 07/31/2008 | US20080181909 Chimeric immunomodulatory compounds and methods of using the same |
| 07/31/2008 | US20080181904 Contains collagen-like domain and Clq domain; idiotypic antibodies; humanizing; biosynthesis |
| 07/31/2008 | US20080181902 Mutant protofibril for active immunisation; synuclein genes, proteins; Parkinson's disease; dementia |
| 07/31/2008 | CA2696603A1 Jc virus vaccine |
| 07/31/2008 | CA2676098A1 Soluble fcgammaria and related methods |
| 07/31/2008 | CA2675625A1 Chronic rejection inhibitor |
| 07/31/2008 | CA2675521A1 Human cancer stem cells |
| 07/31/2008 | CA2675293A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2675292A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2674897A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2669412A1 Optimized cd40 antibodies and methods of using the same |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950299A1 Mammalian receptor proteins; related reagents and methods |
| 07/30/2008 | EP1950296A2 Oligodeoxynucleotide and its use to induce an immune response |
| 07/30/2008 | EP1950294A1 Novel cell penetrating peptide |
| 07/30/2008 | EP1950226A2 Receptors for human interleukin-12 |
| 07/30/2008 | EP1950205A1 Method for stabilization of isoxazole compound |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1949107A1 Negative immunomodulation of immune responses by nkg2d-positive cd4-positive cells |
| 07/30/2008 | EP1948818A2 Use of b cell expansion agents in generating antibodies |